Journal of International Oncology››2015,Vol. 42››Issue (2): 91-94.doi:10.3760/cma.j.issn.1673-422X.2015.02.004
Previous ArticlesNext Articles
Zeng Hai, Zhang Weijia, Li Shuang
Online:
2015-02-08Published:
2015-02-02Contact:
Zeng Hai E-mail:zenghai0716@163.comZeng Hai, Zhang Weijia, Li Shuang. Analysis of the failure pattern in 110 patients with radical resection of gastric cancer[J]. Journal of International Oncology, 2015, 42(2): 91-94.
[1] Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction[J]. N Engl J Med, 2010, 345(10): 725-730. [2] Demir G, Unsal D, Zengin N, et al. Analysis of resected gastric cancer in Turkish population[J]. Hepatogastroenterology, 2013, 60(126): 1535-1540. [3] Eom BW, Yoon H, Ryu KW, et al. Predictors of timing and patterns of recurrence after curative resection for gastric cancer[J]. Dig Surg, 2010, 27(6): 481486. [4] Wu B, Wu D, Wang M, et al. Recurrence in patients following curative resection of early gastric carcinoma[J]. J Surg Oncol, 2008, 98(6): 411414. [5] 严超, 朱正纲, 燕敏, 等. 多排CT对胃癌腹膜转移术前预测的单中心大宗病例研究[J]. 中华胃肠外科杂志, 2010, 13(2): 106110. [6] Park JC, Lee YC, Kim JH, et al. Clinicopathological features and prognostic factors of proximal gastric carcinoma in a population with high Helicobacter pylori prevalence: a singlecenter, largevolume study in Korea[J]. Ann Surg Oncol, 2010, 17(3): 829-837. [7] Lim DH, Kim DY, Kang MK, et al. Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist′s view[J]. Br J Cancer, 2004, 91(1): 11-17. [8] Zhang X, Li N, Wei W, et al. Clinical management of gastric cancer: results of a multicenter survey[J]. BMC Cancer, 2011, 11: 369. [9] Li JH, Zhang SW, Liu J, et al. Review of clinical investigation on recurrence of gastric cancer following curative resection[J]. Chin Med J (Engl), 2012, 125(8): 1479-1495. [10] Roviello F, Marrelli D, de Manzoni G, et al. Prospective study of peritoneal recurrence after curative surgery for gastric cancer[J]. Br J Surg, 2003, 90(9): 1113-1119. [11] 吴亮亮, 梁寒, 王晓娜, 等. 胃癌根治术后早期复发转移的相关因素分析[J]. 中华外科杂志, 2010, 48(20): 1542-1545. [12] 王志明, 庄荣源, 陈勇, 等. 化疗联合腹腔灌注细胞因子诱导的杀伤细胞治疗胃癌腹水[J]. 中华胃肠外科杂志, 2013, 16(1): 28-31. [13] Choi JY, Ha TK, Kwon SJ. Clinicopathologic characteristics of gastric cancer patients according to the timing of the recurrence after curative surgery[J]. J Gastric Cancer, 201l, 11(1): 46-54. [14] He MM, Wu WJ, Wang F, et al. S1based chemotherapy versus capecitabinebased chemotherapy as firstline treatment for advanced gastric carcinoma: a metaanalysis[J]. PLos One, 2013, 8(12): 1-17. [15] 秦玉娥, 周福祥, 戴静, 等. 进展期胃癌根治术后放化疗与单纯化疗预后分析[J]. 中华放射肿瘤学杂志, 2013, 22(4): 263-265. |
[1] | Qian Xiaotao, Shi Ziyi, Hu Ge, Wu Xiaowei.Efficacy of consolidation chemotherapy after radical radiotherapy and chemotherapy for stage Ⅲ-ⅣA esophageal squamous cell carcinoma: a real-world clinical study[J]. Journal of International Oncology, 2024, 51(6): 326-331. |
[2] | Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun.Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer[J]. Journal of International Oncology, 2024, 51(6): 332-337. |
[3] | Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343. |
[4] | Gao Fan, Wang Ping, Du Chao, Chu Yanliu.Research progress on intestinal flora and non-surgical treatment of the colorectal cancer[J]. Journal of International Oncology, 2024, 51(6): 376-381. |
[5] | Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin.Study on the clinical relationship between inflammatory burden index and gastric cancer[J]. Journal of International Oncology, 2024, 51(5): 274-279. |
[6] | Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234. |
[7] | Qian Xiaotao, Shi Ziyi, Hu Ge.A real-world clinical study of immunocheckpoint inhibitor maintenance therapy after radical radiotherapy and chemotherapy in stage Ⅲ-ⅣA esophageal squamous cell carcinoma[J]. Journal of International Oncology, 2024, 51(3): 151-156. |
[8] | Xie Shuping, Sun Yahong, Wang Chao.Prediction of efficacy of early-stage tumor markers combined with NLR and PLR for immunotherapy in gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 157-165. |
[9] | Li Shuyue, Ma Chenying, Zhou Juying, Xu Xiaoting, Qin Songbing.Progress of radiotherapy in oligometastatic non-small cell lung cancer[J]. Journal of International Oncology, 2024, 51(3): 170-174. |
[10] | Liu Yulan, Jing Haiyan, Sun Jing, Song Wei, Sha Dan.Advances in predicting efficacy and prognostic markers of immunotherapy for gastric cancer[J]. Journal of International Oncology, 2024, 51(3): 175-180. |
[11] | Yue Hongyun, Zhang Baihong.Differentiation therapies in human cancers[J]. Journal of International Oncology, 2024, 51(2): 109-113. |
[12] | Jin Xudong, Chen Zhongjian, Mao Weimin.Research progress on the role of MTAP in malignant mesothelioma[J]. Journal of International Oncology, 2024, 51(2): 99-104. |
[13] | Gao Xinyu, Li Zhenjiang, Sun Hongfu, Han Dan, Zhao Qian, Liu Chengxin, Huang Wei.Clinical application of MR-guided radiotherapy based on MR-linac in esophageal cancer patients[J]. Journal of International Oncology, 2024, 51(1): 37-42. |
[14] | Cui Tenglu, Lyu lu, Sun Pengfei.Application of radiotherapy combined with immunotherapy in the treatment of head and neck squamous cell carcinoma[J]. Journal of International Oncology, 2023, 50(9): 548-552. |
[15] | Shao Huifang, Wang Xuehong, Lu Yongfu.Mechanism of action and clinical significance of CST1 in the progression of gastric cancer[J]. Journal of International Oncology, 2023, 50(8): 489-492. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||